Electronic Cardiovascular Device-associated to Infective Endocarditis Caused by Mycobacterium Mageritense
Journal: Advances in Medicine and Engineering Interdisciplinary Research DOI: 10.32629/ameir.v2i4.2834
Abstract
Rapidly growing non-tuberculosis mycobacteria are a rare cause of bacterial endocarditis. During the last decades, there has been an increase in infections due to rapidly growing mycobacteria, especially after trauma and postoperative procedures, both localized and disseminated, as well as nosocomial outbreaks due to contamination of medical equipment. Routine acid-fast staining for blood culture bottles is not always performed. However, the microbiologist should be aware of potential RGM infections especially when gram-positive bacilli are observed. We describe a case of endocarditis caused by mycobacterium mageritense in a patient with an autologous pericardial patch and a pressure catheter in the left auricle. The bacterial species was identified as mycobacterium mageritense by mass spectrometry (MALDI-TOF MS), score 2.3, and confirmed by 16S rRNA analysis with 99.8 and 100% agreement, respectively.
Keywords
infective endocarditis; electronic cardiovascular device; mycobacterium mageritense; mass spectrometry
Full Text
PDF - Viewed/Downloaded: 0 TimesReferences
[1] Casal MM, Casal M. Las micobacterias atípicas como patógenos emergentes. Enf Emerg. 2000;2:220-30.
[2] Cattani ME, Posse T, Hermes RL, Kaufman SC. Identificación rápida de microorganismos de frascos de hemocultivos por espectrometría de masas. Comparación de 2 procedimientos diagnósticos. Rev Argent Microbiol. 2015;47:190-5.
[3] De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis. 2006;42:1756-63.
[4] Domenech P, Jimenez MS, Menendez MC, Bull TJ, Samper S, Manrique A, Garcia MJ. Mycobacterium mageritense sp. nov. Int J Syst Bacteriol. 1997;47:535-40.
[5] Esteban J, Fernández Roblas R, Soriano F. Micobacterias de crecimiento rápido en patología humana. Enferm Infecc Microbiol Clin. 2000;18:279-86.
[6] Fukunaga M, Goya M, Ogawa M, Fukuda K, Taniguchi H, Ando K, Iwabuchi M, Miyazaki H. Implantable cardioverter defibrillator infection due to Mycobacterium mageritense. J Infect Chemother. 2016;22:180-3.
[7] Martín de Hijas NZ, García Almeida D, Ayala G, Fernández Roblas R, Gadea I, Celdrán A, Gómez-Barrena E, Esteban J. Biofilm development by clinical strains of non-pigmented rapidly growing mycobacteria. Clin Microbiol Infect. 2009;15:931-6.
[8] McMullen AR, Mattar C, Kirmani N, Burnham CA. Brown-pigmented Mycobacterium mageritense as a cause of prosthetic valve endocarditis and bloodstream infection. J Clin Microbiol. 2015;53:2777-80.
[9] Monteserin J, Paul R, Lopez B, Cnockaert M, Tortoli E, Menéndez C, García MJ, Palomino JC, Vandamme P, Ritacco V, Martin A. Combined approach to the identification of clinically infrequent non-tuberculous mycobacteria in Argentina. Int J Tuberc Lung Dis. 2016;20:1257-62.
[10] Telenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol. 1993;31:175-8.
[11] Wagner D, Young LS. Nontuberculous mycobacterial infections: A clinical review. Infection. 2004;32:257-70.
[12] Wallace RJ Jr, Bedsole G, Sumter G, Sanders CV, Steele LC, Brown BA, Smith J, Graham DR. Activities of cipro- floxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother. 1990;34:65-70.
[13] Wallace RJ Jr, Brown BA, Silcox VA, Tsukamura M, Nash DR, Steele LC, Steingrube VA, Smith J, Sumter G, Zhang Y, Blacklock Z. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium for tuitum. J Infect Dis. 1991;163:598-603.
[14] Wallace RJ Jr, Brown-Elliot BA, Hall L, Roberts G, Wilson RW, Mann LB, Crist CJ, Chiu SH, Dunlap R, Garcia MJ, Bagwell JT, Jost KC Jr. Clinical and laboratory features of Mycobacterium mageritense. J Clin Microbiol. 2002;40:2930-5.
[2] Cattani ME, Posse T, Hermes RL, Kaufman SC. Identificación rápida de microorganismos de frascos de hemocultivos por espectrometría de masas. Comparación de 2 procedimientos diagnósticos. Rev Argent Microbiol. 2015;47:190-5.
[3] De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis. 2006;42:1756-63.
[4] Domenech P, Jimenez MS, Menendez MC, Bull TJ, Samper S, Manrique A, Garcia MJ. Mycobacterium mageritense sp. nov. Int J Syst Bacteriol. 1997;47:535-40.
[5] Esteban J, Fernández Roblas R, Soriano F. Micobacterias de crecimiento rápido en patología humana. Enferm Infecc Microbiol Clin. 2000;18:279-86.
[6] Fukunaga M, Goya M, Ogawa M, Fukuda K, Taniguchi H, Ando K, Iwabuchi M, Miyazaki H. Implantable cardioverter defibrillator infection due to Mycobacterium mageritense. J Infect Chemother. 2016;22:180-3.
[7] Martín de Hijas NZ, García Almeida D, Ayala G, Fernández Roblas R, Gadea I, Celdrán A, Gómez-Barrena E, Esteban J. Biofilm development by clinical strains of non-pigmented rapidly growing mycobacteria. Clin Microbiol Infect. 2009;15:931-6.
[8] McMullen AR, Mattar C, Kirmani N, Burnham CA. Brown-pigmented Mycobacterium mageritense as a cause of prosthetic valve endocarditis and bloodstream infection. J Clin Microbiol. 2015;53:2777-80.
[9] Monteserin J, Paul R, Lopez B, Cnockaert M, Tortoli E, Menéndez C, García MJ, Palomino JC, Vandamme P, Ritacco V, Martin A. Combined approach to the identification of clinically infrequent non-tuberculous mycobacteria in Argentina. Int J Tuberc Lung Dis. 2016;20:1257-62.
[10] Telenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol. 1993;31:175-8.
[11] Wagner D, Young LS. Nontuberculous mycobacterial infections: A clinical review. Infection. 2004;32:257-70.
[12] Wallace RJ Jr, Bedsole G, Sumter G, Sanders CV, Steele LC, Brown BA, Smith J, Graham DR. Activities of cipro- floxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother. 1990;34:65-70.
[13] Wallace RJ Jr, Brown BA, Silcox VA, Tsukamura M, Nash DR, Steele LC, Steingrube VA, Smith J, Sumter G, Zhang Y, Blacklock Z. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium for tuitum. J Infect Dis. 1991;163:598-603.
[14] Wallace RJ Jr, Brown-Elliot BA, Hall L, Roberts G, Wilson RW, Mann LB, Crist CJ, Chiu SH, Dunlap R, Garcia MJ, Bagwell JT, Jost KC Jr. Clinical and laboratory features of Mycobacterium mageritense. J Clin Microbiol. 2002;40:2930-5.
Copyright © 2024 Silvia Tützer, Tamara Posse, Roxana Paul, Johana Monteserin, Hector Pérez, Sara Kaufman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License